Dr. Kornman is Editor-in-Chief of the Journal of Periodontology and Adjunct Research Professor in the Department of Periodontics and Oral Medicine at the University of Michigan. Previously, Dr. Kornman was cofounder and Chief Scientific Officer of Interleukin Genetics, a diagnostics company focused on chronic inflammatory diseases, including periodontitis, cardiovascular disease, and osteoarthritis. Dr. Kornman is currently CEO of a molecular diagnostics company based in London. Prior to entering industry, he was Professor and Chairman of Periodontology and Professor of Microbiology and Immunology at the University of Texas Health Science Center at San Antonio. Dr. Kornman has published extensively, including papers in Science, New England Journal of Medicine, Journal of American College of Cardiology, Human Molecular Genetics, Annals of Rheumatic Diseases, and various dental journals. Much of Dr. Kornman?s career has focused on translating research into clinical use. This includes several issued U.S. patents and multiple years of assessing new technology generated within the Division of Genomic Medicine at the University of Sheffield Medical School in the UK. Dr. Kornman received his DDS from Emory University, as well as a specialty in periodontology and a PhD from the University of Michigan. His mentors were Sig Ramfjord and Harald Löe.